Eléments de l'association

	Stephen Locarnini	9
	Résistance	92
	Stephen Locarnini *Sauf* Résistance"	5
	Résistance *Sauf* Stephen Locarnini"	88
	Stephen Locarnini Et Résistance	4
	Stephen Locarnini Ou Résistance	97
	*Corpus*	11069

List of bibliographic references

Number of relevant bibliographic references: 4.

Ident.	Authors (with country if any)	Title
000D81	Robert Gish [États-Unis] ; Ji-Dong Jia [République populaire de Chine] ; Stephen Locarnini [Australie] ; Fabien Zoulim [France]	Selection of chronic hepatitis B therapy with high barrier to resistance
003643	Julie Sheldon [Espagne] ; Belen Ramos [Espagne] ; Javier Garcia-Samaniego ; Pilar Rios [Espagne] ; Angeline Bartholomeusz [Australie] ; Miriam Romero ; Stephen Locarnini [Australie] ; Fabien Zoulim [France] ; Vincent Soriano [Espagne]	Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity
004A76	Stephen Locarnini [Australie] ; Angelos Hatzakis [Grèce] ; Jenny Heathcote [Canada] ; Emmet B. Keeffe [États-Unis] ; T. Jake Liang [États-Unis] ; David Mutimer [Royaume-Uni] ; Jean-Michel Pawlotsky [France] ; Fabien Zoulim [France]	Management of antiviral resistance in patients with chronic hepatitis B
005326	Anna S. F. Lok [États-Unis] ; Fabien Zoulim [France] ; Stephen Locarnini [Australie] ; Alessandra Mangia [Italie] ; Grazia Niro [Italie] ; Hilde Decraemer [Belgique] ; Geert Maertens [Belgique] ; Frank Hulstaert [Belgique] ; Karen De Vreese [Belgique] ; Erwin Sablon [Belgique]	Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: Evaluation of performance of INNO-LiPA HBV DR assay

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024